Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943. Policy Forum Jun 2008 The Strains and Drains of Long-Term Care Richard W. Johnson, PhD Virtual Mentor. 2008;10(6):397-400. doi: 10.1001/virtualmentor.2008.10.6.pfor1-0806. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Podcast Jul 2020 Ethics Talk: Improvising Health Care Kelly Leonard, executive director of insights and applied improvisation at Second City Works, relates how improvisation can help clinicians build relationships with patients and improve their outcomes. Viewpoint Sep 2006 Suffering under the Auspices of Contemporary Medicine Rashmi Kudesia, ScB Virtual Mentor. 2006;8(9):617-621. doi: 10.1001/virtualmentor.2006.8.9.oped2-0609. Medicine and Society Oct 2006 Talking with Families about Severely Disabled Children Arthur F. Kohrman, MD Virtual Mentor. 2006;8(10):685-688. doi: 10.1001/virtualmentor.2006.8.10.msoc1-0610. Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Nov 2019 Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant? Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD Success depends on strong support, rehabilitation, adherence, and social integration. AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943.
Policy Forum Jun 2008 The Strains and Drains of Long-Term Care Richard W. Johnson, PhD Virtual Mentor. 2008;10(6):397-400. doi: 10.1001/virtualmentor.2008.10.6.pfor1-0806.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Podcast Jul 2020 Ethics Talk: Improvising Health Care Kelly Leonard, executive director of insights and applied improvisation at Second City Works, relates how improvisation can help clinicians build relationships with patients and improve their outcomes.
Viewpoint Sep 2006 Suffering under the Auspices of Contemporary Medicine Rashmi Kudesia, ScB Virtual Mentor. 2006;8(9):617-621. doi: 10.1001/virtualmentor.2006.8.9.oped2-0609.
Medicine and Society Oct 2006 Talking with Families about Severely Disabled Children Arthur F. Kohrman, MD Virtual Mentor. 2006;8(10):685-688. doi: 10.1001/virtualmentor.2006.8.10.msoc1-0610.
Letter to the Editor Sep 2006 Commercial Labs Offer High Quality Services Herman Hurwitz, MD Virtual Mentor. 2006;8(9):C1-C3. doi: 10.1001/virtualmentor.2006.8.9.corr1-0609.